Advisory Council on the Misuse of Drugs. (2009) Consideration of the major cannabinoid agonists. London: Home Office.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Cannabinoid agonists)
- Published Version
131kB |
This report draws on much of the evidence cited in the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) assessment of the synthetic cannabinoid receptor agonists, based on an expert meeting held in Lisbon on 6th March 2009.
[For an updated report see the related link below.]
Item Type
Report
Publication Type
International, Report
Drug Type
Cannabis, CNS stimulants
Intervention Type
Harm reduction
Source
Date
2009
Pages
29 p.
Publisher
Home Office
Corporate Creators
Advisory Council on the Misuse of Drugs
Place of Publication
London
EndNote
Accession Number
HRB (Electronic Only)
Related (external) link
Subjects
B Substances > Cannabis product (Cannabinoids)
B Substances > New (novel) psychoactive substances
B Substances > New (novel) psychoactive substances > Synthetic cannabinoids (Spice / K2 / OXIZID / HHC)
L Social psychology and related concepts > Legal availability or accessibility
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
VA Geographic area > Europe > United Kingdom
B Substances > New (novel) psychoactive substances
B Substances > New (novel) psychoactive substances > Synthetic cannabinoids (Spice / K2 / OXIZID / HHC)
L Social psychology and related concepts > Legal availability or accessibility
MP-MR Policy, planning, economics, work and social services > Policy > Policy on substance use
VA Geographic area > Europe > United Kingdom
Repository Staff Only: item control page